Risk factors
Rocket Pharmaceuticals (RCKT) risk factors
Item 1A of every Rocket Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors63 risks2 new10 dropped10 reworded
Rocket Pharmaceuticals implemented a 30% workforce reduction to cut operating expenses by 25% and extend cash runway.
Filed Feb 26, 2026 - FY2024 10-K risk factors71 risks
Rocket Pharmaceuticals faces heavy risks around unproven gene therapies, lack of commercial revenue, capital burn, and manufacturing constraints.
Filed Feb 27, 2025